Aristocrat Leisure (ASX:ALL) profit jumps up: ASX tracking 1.1% lower at noon

Aristocrat Leisure (ASX:ALL) profit jumps up: ASX tracking 1.1% lower at noon

20 Nov 2019 - The ASXt drifted lower at the open following soft leads from Wall Street and is now tracking 1.1% lower at noon. TechnologyOne (ASX:TNE) shares are on the rise today after a dip yesterday after reporting a strong increase in profit. ...
Finance News Network

More Shows by Finance News Network

PolyNovo (ASX:PNV) supplies burn cream to volcano victims: ASX closed 1.6% higher

PolyNovo (ASX:PNV) supplies burn cream to volcano victims: ASX closed 1.6% higher

16 Dec 2019 - It has been a huge day of trade for the ASX seeing its biggest one day gain since February. After rising at the open it continued to climb closing 1.6% higher. Nearmap (ASX:NEA) is now the biggest gainer. PolyNovo (ASX:PNV) has suppl...
Sienna Cancer Diagnostics (ASX:SDX) capital raising

Sienna Cancer Diagnostics (ASX:SDX) capital raising

16 Dec 2019 - Sienna Cancer Diagnostics Limited (ASX:SDX) Managing Director and CEO Carl Stubbings talks about the company's capital raising and co-development of tests using its SIEN-NET liquid biopsies platform technology.
Openpay Group (ASX:OPY) lists on ASX

Openpay Group (ASX:OPY) lists on ASX

16 Dec 2019 - Openpay Group (ASX:OPY) CEO & MD, Michael Eidel talks about its business model, size of the opportunity and how it differentiates itself from other buy now pay later (BNPL) providers.
US-China trade deal 'totally done', according to Trump aide: ASX tracking 1.2% higher at noon

US-China trade deal 'totally done', according to Trump aide: ASX tracking 1.2% higher at noon

16 Dec 2019 - The ASX has risen at the open following some small positive leads from Wall Street. It is now tracking 1.2% higher at noon. On Friday US and Chinese officials announced they had finally agreed to the phase one agreement after an 18-m...
Botanix Pharmaceuticals (ASX:BOT) clinical trial update

Botanix Pharmaceuticals (ASX:BOT) clinical trial update

16 Dec 2019 - Botanix Pharmaceuticals Limited (ASX:BOT) Founder Matthew Callahan talks about the company's Phase 2 US trial results for severe acne, plans for its Phase 3 trails, including FDA input, its Phase 2 atopic dermatitis study, and what i...
Keytone’s (ASX:KTD) New Zealand facility gets regulatory tick of approval

Keytone’s (ASX:KTD) New Zealand facility gets regulatory tick of approval

16 Dec 2019 - Keytone Dairy Corporation (ASX:KTD) has received all regulatory approvals for its second manufacturing facility in New Zealand allowing it to manufacture and export formulated dairy nutritional products.
API (ASX:API) sells shares in Sigma Healthcare

API (ASX:API) sells shares in Sigma Healthcare

16 Dec 2019 - Australian Pharmaceutical Industries (ASX:API) has sold all of its shares in said that it had today Sigma Healthcare.
Beach (ASX:BPT) provides Beharra Springs Deep update

Beach (ASX:BPT) provides Beharra Springs Deep update

16 Dec 2019 - Beach Energy Limited (ASX:BPT) has completed flow testing at the Beharra Springs Deep-1 gas discovery in licence L11 in the Perth Basin.